✦ LIBER ✦

Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication

✍ Scribed by Jonathan W. Stewart; Uriel Halbreich

Book ID: 118318046
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 513 KB
Volume: 25
Category: Article
ISSN: 0006-3223
DOI: 10.1016/0006-3223(89)90144-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effects of antidepressant medication

The effects of antidepressant medication on the diurnal plasma cortisol levels in depressed patients

✍ D.J. McClure 📂 Article 📅 1966 🏛 Elsevier Science 🌐 English ⚖ 418 KB

D-Fenfluramine responses in depression b

D-Fenfluramine responses in depression before and after antidepressant treatment

✍ A.J. Cleare; R.M. Murray; V. O’Keane 📂 Article 📅 1996 🏛 Elsevier Science 🌐 French ⚖ 132 KB

Effects of Antidepressant Medication on

Effects of Antidepressant Medication on Morbidity and Mortality in Depressed Patients After Myocardial Infarction

✍ C.B. Taylor; M.E. Youngblood; D. Catellier; R.C. Veith 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Plasma melatonin and cortisol circadian

Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment

✍ P. Monteleone; F. Catapano; A. Tortorella; S. Di Martino; M. Maj 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 677 KB

Antidepressive medication and diurnal va

Antidepressive medication and diurnal variation of plasma 17-OHCS levels in depression

✍ Ranan Rimón; Simo Salonen; Aimo Pekkarinen 📂 Article 📅 1968 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Milnacipran plasma levels and antidepres

Milnacipran plasma levels and antidepressant response in Japanese major depressive patients

✍ Hisashi Higuchi; Keizo Yoshida; Hitoshi Takahashi; Shingo Naito; Mitsuhiro Kamat 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract The relationship between antidepressant effects and plasma levels of milnacipran was studied in 49 cases of major depression without psychotic features during 6 weeks of milnacipran treatment. The daily dose of milnacipran was 50 mg/day for the first week, and up to 100 mg/day thereafte